Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Raasch B - Imiquimod 5% cream has been shown to stimulate the innate and cell mediated immune system. The short-term success of imiquimod 5% cream in randomized controlled trials comparing different treatment regimes and dosing as a treatment for small superficial basal cell carcinoma (BCC) not on the face or neck is in the range of 82% for 5 times per week application. A high proportion of participants with good response rates to topical treatment (58%–92%) experience local side effects such as itching and burning, less commonly erosion and ulceration, but the proportion of participants ceasing treatment has not been high.


 

Related Articles

Cytokeratin expression patterns in multiple infundibulocystic basal cell carcinoma
Journal of Cutaneous Pathology, 10/28/09    Relevance Score: 82%

Big Bad BCCs: craniofacial resection and reconstruction for atypical basal cell carcinoma
Journal of Plastic, Reconstructive & Aesthetic Surgery, 11/03/09    Relevance Score: 81%

Basal Cell Carcinoma of the Nipple-Areola Complex
Dermatologic Surgery, 11/17/09    Relevance Score: 80%

Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies
International Journal of Dermatology, 11/12/09    Relevance Score: 80%

Multidrug Resistance in a Urothelial Cancer Cell Line After 1-Hour Mitomycin C Exposure
The Journal of Urology, 10/29/09    Relevance Score: 80%

Today in Dermatopathology...keeping you current

Cutaneous Lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index Instrument
Rheumatic Disease Clinics of North America, 03/15/10

Regional nerve blockade prior to direct injection to achieve anaesthesia of the nasal ala
British Journal of Dermatology, 03/15/10

Topical 0.03% atropine vs. 15% aluminum chloride in treating multiple eccrine hidrocystomas: A randomized single blind controlled study
Indian Journal of Dermatology, 03/15/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address